Policy & Regulation
AnaCardio secures US patent for AC01, extending protection until 2042
11 March 2026 - KDventures AB (STO:KDV), a Nordic investment company focused on life sciences, announced on Wednesday that its portfolio company AnaCardio AB has received US patent approval for AC01, ...
Dexcom highlights new diabetes outcomes and product roadmap at ATTD 2026
11 March 2026 - DexCom Inc announced on Wednesday that it will present new clinical and real-world evidence demonstrating the benefits of its glucose biosensing technology at the Advanced Technologies...
Curatis and Neupharma partner to develop corticorelin for peritumoral brain edema in Japan
11 March 2026 - Drug company Curatis Holding AG and Japanese pharmaceutical company Neupharma Co, Ltd announced on Wednesday that they have signed an exclusive licensing and development agreement to c...
Samsung Biologics collaborates with Lilly for new Gateway Labs site in Korea
11 March 2026 - Samsung Biologics (KRX:207940), a contract development and manufacturing organisation (CDMO) based in South Korea, announced on Tuesday that it has entered into a collaboration agreeme...
Citius Oncology reports positive topline results from Phase 1 clinical trial of LYMPHIR combination
11 March 2026 - Oncology-focused biopharmaceutical company Citius Oncology Inc (Nasdaq:CTOR), a majority-owned subsidiary of Citius Pharmaceuticals Inc (Nasdaq:CTXR), on Tuesday reported positive topl...
CMIC agrees agentic AI partnership with Bluenote
11 March 2026 - CMIC Co Ltd, a contract research organisation (CRO) jointly owned by US investment firm Blackstone and Japan-based CMIC HOLDINGS Co Ltd, announced on Tuesday that it has partnered with...